Cc1cc(C)c2oc(C(=O)Nc3c(C(=O)c4ccc(F)cc4)oc4ccccc34)cc(=O)c2c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?